Service & Solutions
40%
Average reduction in length of lyo cycle after R&D support
65%
Average increase in productivity after R&D support
80%
Average reduction in cost of storage after R&D support
60%
Average reduction in cost of production after R&D support
Biopharma Group is ISO:9001 & ISO:13485 Accredited
Pharma CDMO Services
Clinical Manufacturing Services
Diagnostic CDMO Services
HPAPIs & Cytotoxic Handling
Analytical Lyo Instruments
Lyophilization Training Courses
More Information
Biopharma Group’s contract R&D services focus on freeze drying (dried product) and liquid formulation development – allowing us to offer a comprehensive range of expert led CDMO services. Analysis options include comparable process studies, formulation & cycle development, process reviews/audits, optimisation and scale-up that incorporate PAT (Process Analysis Technology) for risk-based quality assurance.
Lyobeads, aka lyophilized spheres, have become a popular technology in the field of freeze drying to the diagnostics industry - as the primary advantage is their flexibility in formulation. They allow for the development of a single formulation that can be easily adjusted for various applications, even in different container types. This versatility can significantly reduce research and development (R&D) investment, making lyobeads an attractive option for companies looking for diagnostic and manufacturing assistance.
Diagnostics: Our CDMO specialists are experts in formulation development and lyophilisation processes. This means that the lab teams at Biopharma Group have the capability to support the creation of stable and efficient diagnostic reagents and test kits, enhancing the accuracy and reliability of diagnostic tests.
Quality by Design (QbD) is revolutionising pharmaceutical development by replacing traditional trial-and-error methods. As part of our CDMO services Biopharma Group champions this approach - significantly reducing the number of developmental cycles needed for formulation and lyophilisation process optimisation.
Biopharma Group is at the forefront of pharmaceutical research and development, boasting three in-house, state-of-the-art low bio-burden labs. These facilities demonstrate our commitment to precision and safety in lyophilization processes and the manufacturing of dried and liquid formulations.
Our ISO 13485 accreditation is a testament to Biopharma Group's commitment to quality and compliance as a provider of CDMO services. This certification ensures that our processes, from research and development to manufacturing, adhere to the highest global standards.
Don’t Just Take Our Word For It
“We are very grateful for our collaboration with Biopharma Group and for their valuable help in the development of our lyophilization process. Their expertise and commitment played an important role in achieving results that exceeded our expectations. As a testament to our joint effort, we launched our first lyo-compatible qPCR mix - SolisFAST® Lyo- Ready qPCR Kit with UNG. We appreciate their genuine dedication to our project and look forward to continued success together.”
“Through my experience of working with Biopharma Group on various lyo projects, I can happily say that I have always been super impressed with the results that we have received! We will definitely continue to make Biopharma Group our first choice when needing to outsource freeze drying support.”
We have had the opportunity to work with Biopharma Group on several projects to optimize and improve freeze-drying processes. Biopharma Group has real expertise that is put to the benefit of its customers. The responsiveness of their teams and the tools used have always been highly appreciated.
We worked with Biopharma group very intensively around Lyo project development. I was very much impressed and enjoyed working with the team that provided detailed, and regular updates on project progress, challenges, and solutions.
The information provided by the Biopharma Group team helped me to improve the quality of our product, and in particular helped me to develop more effective and efficient processes for transferring our products from research to the production stage.
Theragenix has benefited from Biopharma Group services to develop a formulation suitable for lyophilisation. The project involved a freeze drying cycle and a series of analyses for stability studies. Both technical and commercial support has been very appreciated
“Thank you for being so professional, helpful, innovative and friendly. We were extremely impressed with the quality of your service.”
“We elected to work with Biopharma because of their full service and years of experience. They helped us with analysis and troubleshooting of our product and we were impressed by the quality and responsiveness of their scientists. We would definitely use them again.”
“Biopharma developed a successful cycle for us, their quality and technical support was excellent.”
“Biopharma helped develop our cycle, we are extremely satisfied with their quality and service and would thoroughly recommend them to others.”
“Biopharma Group quickly understood our radiopharmaceutical challenges and provided effective solutions. Their team is highly responsive, knowledgeable, and a pleasure to work with.”
“We chose Biopharma because of their reputation and expertise in the field of lyophilisation and we were impressed with their overall excellent level of service. We would recommend them.”
"Biopharma Group always offered fast and reliable results in our Freeze Dry Microscopy studies. Big thanks for a great team!"
“We worked with Biopharma Group for the development and deployment of an antibody freeze drying process to support preclinical studies. They rapidly provided technical insights to guide the design of the process development study and helped troubleshoot unexpected results. The team’s experience was critical to the success of this project, and we benefitted from an open and collaborative approach throughout.”
